Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. (Oncotarget, 2016)

(untitled) - Campa, D; Pastore, M; Gentiluomo, M; Talar-Wojnarowska, R; Kupcinskas, J; Malecka-Panas, E; Neoptolemos, J; Niesen, W; Vodicka, P; Delle Fave, G; Bas Bueno-de-Mesquita, H; Gazouli, M; et al.